Palisade Bio, Inc. (PALI) has a market capitalization of $341.72M and trades at $2.06. The 52-week range is 0.53-2.64.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.9, Earnings Per Share (EPS) of $-0.30.
The stock has a beta of 1.47, operates in the Healthcare sector.
